2015/0309(CNS) | [ParlTrack]

Changes: 2023/08/03events.date, docs, 2021/12/18procedure.Modified_legal_basis, events, docs.docs.url, events.docs.url, events.type, procedure.Other_legal_basis, 2020/01/19committees, events.docs.url, 2019/07/12committees, 2019/07/06council, procedure.Modified_legal_basis, events, procedure.dossier_of_the_committee, activities, committees, procedure.subject, docs, links, other, commission, procedure.title, procedure.final.url

View current state | View Changes for this date

Procedure completed

2015/0309(CNS) Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures. Implementing Decision

Role	Committee	Rapporteur	Shadows
Opinion	ENVI
Lead	LIBE	BONI Michał (EPP)	HEDH Anna (S&D), PAGAZAURTUNDÚA RUIZ Maite (ALDE), VALERO Bodil (Verts/ALE)

Lead committee dossier: LIBE/8/05453

Subjects

Links

Activites

2016/07/02 Final act published in Official Journal
- Decision 2016/1070
- OJ L 178 02.07.2016, p. 0018
#3479
2016/06/27 Council Meeting
2016/06/27 End of procedure in Parliament
2016/06/27 Act adopted by Council after consultation of Parliament
2016/06/08 Decision by Parliament, 1st reading/single reading
- T8-0258/2016 summary
  
  The European Parliament adopted by 646 votes to 7, with 21 abstentions, a legislative resolution on the draft Council decision on subjecting the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures. In line with the recommendation made by the Committee on Civil Liberties, Justice and Home Affairs, Parliament approved the draft Council decision which aims to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union.
2016/05/10 Committee report tabled for plenary, 1st reading/single reading
- A8-0175/2016 summary
  
  The Committee on Civil Liberties, Justice and Home Affairs adopted, in the framework of a special legislative procedure (Parliament’s consultation), the report by Michał BONI (EPP, PL) on the draft Council decision on subjecting the new psychoactive substance 1phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, αPVP) to control measures. The committee approved the draft Council decision without amendments. To recall, the proposed Decision seeks to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union.
2016/04/28 Vote in committee, 1st reading/single reading
2016/04/11 Committee referral announced in Parliament, 1st reading/single reading
2015/12/21 Legislative proposal published
- 15386/2015 summary
  
  PURPOSE: to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures. PROPOSED ACT: Council Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: a risk assessment report on the new psychoactive substance α-PVP was drawn up in compliance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction, and was subsequently submitted to the Commission and to the Council on 27 November 2015. α-PVP is a potent psychostimulant, structurally related to cathinone, pyrovalerone and Methylendioxypyrovaleron (MDPV) which are controlled under the 1971 United Nations Convention on Psychotropic Substances. There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected. α-PVP has no established or acknowledged medical use (human or veterinary). Despite the limited scientific evidence available on α-PVP, the evidence and information on the health risks that the substance poses, as documented in its detection in fatalities and acute intoxications, provides sufficient ground for subjecting α-PVP to control measures across the Union. CONTENT: the proposed Decision seeks to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures across the Union. Since sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it, subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose. For further details, please report to the summary of the Commission’s initial legislative proposal of 18.12.2015.
- DG {'url': 'http://ec.europa.eu/dgs/home-affairs/', 'title': 'Migration and Home Affairs'}, AVRAMOPOULOS Dimitris
2015/12/18 Initial legislative proposal published
- COM(2015)0674 summary
  
  PURPOSE: to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.PROPOSED ACT: Council Decision.ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.BACKGROUND: the risks of α-PVP were assessed by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addition (EMCDDA), acting in compliance with the provisions of Council Decision 2005/387/JHA. In particular, the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substance α-PVP. The Chair of the Scientific Committee submitted the risk assessment report to the Commission and to the Council on 27 November 2015.α-PVP is a potent psychostimulant. The substance detected in all 28 Member States as well as in Turkey and Norway, is mainly imported into the EU drug market from China and then distributed across Europe.There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected.There is no available information or published studies assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects with those observed with other stimulants.According to the risk assessment report, the acute toxicity of α-PVP is such that it can cause severe harms to the health of individuals. Therefore, the Commission considered that there are grounds for subjecting this substance to control measures across the Union.CONTENT: the objective of this proposal for a Council Decision is to call upon the Member States to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.Currently, sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it. Subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.
- DG {'url': 'http://ec.europa.eu/dgs/home-affairs/', 'title': 'Migration and Home Affairs'}, AVRAMOPOULOS Dimitris

Documents

Initial legislative proposal published: COM(2015)0674
Legislative proposal published: 15386/2015
Committee report tabled for plenary, 1st reading/single reading: A8-0175/2016
Decision by Parliament, 1st reading/single reading: T8-0258/2016
: Decision 2016/1070
: OJ L 178 02.07.2016, p. 0018

History

(these mark the time of scraping, not the official date of the change)

2019-07-06Show (16) Changes | Timetravel

activities	date: 2015-12-18T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2015/0674/COM_COM(2015)0674_EN.pdf title: COM(2015)0674 type: Initial legislative proposal published celexid: CELEX:52015PC0674:EN body: EC commission: DG: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris type: Initial legislative proposal published date: 2015-12-21T00:00:00 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=15386%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 15386/2015 body: EC commission: DG: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris type: Legislative proposal published date: 2016-04-11T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP shadows: group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: Verts/ALE name: VALERO Bodil responsible: True committee: LIBE date: 2016-02-29T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał date: 2016-04-28T00:00:00 body: EP type: Vote in committee, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP shadows: group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: Verts/ALE name: VALERO Bodil responsible: True committee: LIBE date: 2016-02-29T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0175&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0175/2016 type: Committee report tabled for plenary, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP shadows: group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: Verts/ALE name: VALERO Bodil responsible: True committee: LIBE date: 2016-02-29T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał date: 2016-05-10T00:00:00 date: 2016-06-08T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0258 type: Decision by Parliament, 1st reading/single reading title: T8-0258/2016 body: EP type: Decision by Parliament, 1st reading/single reading date: 2016-06-27T00:00:00 body: CSL type: Council Meeting council: Agriculture and Fisheries meeting_id: 3479 date: 2016-06-27T00:00:00 body: EP type: End of procedure in Parliament date: 2016-06-27T00:00:00 body: EP/CSL type: Act adopted by Council after consultation of Parliament date: 2016-07-02T00:00:00 docs: url: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32016D1070 title: Decision 2016/1070 url: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2016:178:TOC title: OJ L 178 02.07.2016, p. 0018 type: Final act published in Official Journal
commission	body: EC dg: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
committees/0	type Responsible Committee body EP associated False committee_full Civil Liberties, Justice and Home Affairs committee LIBE date 2016-02-29T00:00:00 rapporteur name: BONI Michał group: Group of European People's Party abbr: EPP shadows name: HEDH Anna group: Progressive Alliance of Socialists and Democrats abbr: S&D name: PAGAZAURTUNDÚA Maite group: Alliance of Liberals and Democrats for Europe abbr: ALDE name: VALERO Bodil group: Greens/European Free Alliance abbr: Verts/ALE
committees/0	body EP responsible False committee_full Environment, Public Health and Food Safety committee ENVI
committees/1	type Committee Opinion body EP associated False committee_full Environment, Public Health and Food Safety committee ENVI opinion False
committees/1	body EP shadows group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: Verts/ALE name: VALERO Bodil responsible True committee LIBE date 2016-02-29T00:00:00 committee_full Civil Liberties, Justice and Home Affairs rapporteur group: EPP name: BONI Michał
council	body: CSL type: Council Meeting council: Agriculture and Fisheries meeting_id: 3479 url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3479*&MEET_DATE=27/06/2016 date: 2016-06-27T00:00:00
docs	date: 2016-03-16T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE578.806 title: PE578.806 type: Committee draft report body: EP
events	date: 2015-12-18T00:00:00 type: Initial legislative proposal published body: EC docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2015/0674/COM_COM(2015)0674_EN.pdf title: COM(2015)0674 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2015&nu_doc=0674 title: EUR-Lex summary: PURPOSE: to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances. PROPOSED ACT: Council Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: the risks of α-PVP were assessed by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addition (EMCDDA), acting in compliance with the provisions of Council Decision 2005/387/JHA . In particular, the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substance α-PVP. The Chair of the Scientific Committee submitted the risk assessment report to the Commission and to the Council on 27 November 2015. α-PVP is a potent psychostimulant. The substance detected in all 28 Member States as well as in Turkey and Norway, is mainly imported into the EU drug market from China and then distributed across Europe. There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected. There is no available information or published studies assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects with those observed with other stimulants. According to the risk assessment report, the acute toxicity of α-PVP is such that it can cause severe harms to the health of individuals. Therefore, the Commission considered that there are grounds for subjecting this substance to control measures across the Union. CONTENT: the objective of this proposal for a Council Decision is to call upon the Member States to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances. Currently, sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it. Subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose. date: 2015-12-21T00:00:00 type: Legislative proposal published body: EC docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=15386%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 15386/2015 summary: PURPOSE: to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures. PROPOSED ACT: Council Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: a risk assessment report on the new psychoactive substance α-PVP was drawn up in compliance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction, and was subsequently submitted to the Commission and to the Council on 27 November 2015. α-PVP is a potent psychostimulant , structurally related to cathinone, pyrovalerone and Methylendioxypyrovaleron (MDPV) which are controlled under the 1971 United Nations Convention on Psychotropic Substances. There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected. α-PVP has no established or acknowledged medical use (human or veterinary). Despite the limited scientific evidence available on α -PVP, the evidence and information on the health risks that the substance poses, as documented in its detection in fatalities and acute intoxications, provides sufficient ground for subjecting α -PVP to control measures across the Union. CONTENT: the proposed Decision seeks to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one ( α -pyrrolidinovalerophenone, α -PVP) to control measures across the Union . Since sixteen Member States control α -PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it, subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose. For further details, please report to the summary of the Commission’s initial legislative proposal of 18.12.2015. date: 2016-04-11T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP date: 2016-04-28T00:00:00 type: Vote in committee, 1st reading/single reading body: EP date: 2016-05-10T00:00:00 type: Committee report tabled for plenary, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0175&language=EN title: A8-0175/2016 summary: The Committee on Civil Liberties, Justice and Home Affairs adopted, in the framework of a special legislative procedure (Parliament’s consultation), the report by Michał BONI (EPP, PL) on the draft Council decision on subjecting the new psychoactive substance 1phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, αPVP) to control measures. The committee approved the draft Council decision without amendments. To recall, the proposed Decision seeks to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union. date: 2016-06-08T00:00:00 type: Results of vote in Parliament body: EP docs: url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=27199&l=en title: Results of vote in Parliament date: 2016-06-08T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0258 title: T8-0258/2016 summary: The European Parliament adopted by 646 votes to 7, with 21 abstentions, a legislative resolution on the draft Council decision on subjecting the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one ( α -pyrrolidinovalerophenone, α -PVP) to control measures. In line with the recommendation made by the Committee on Civil Liberties, Justice and Home Affairs, Parliament approved the draft Council decision which aims to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union. date: 2016-06-27T00:00:00 type: Act adopted by Council after consultation of Parliament body: EP/CSL date: 2016-06-27T00:00:00 type: End of procedure in Parliament body: EP date: 2016-07-02T00:00:00 type: Final act published in Official Journal summary: PURPOSE: to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures. NON-LEGISLATIVE ACT: Council Implementing Decision (EU) 2016/1070 on subjecting 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures. CONTENT: the Council adopted an implementing decision on subjecting the new psychoactive substance 1 -phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP ) to control measures across the Union. α-PVP is a potent psychostimulant, structurally related to cathinone, pyrovalerone and methylendioxypyrovaleron (MDPV), which are controlled under the 1971 United Nations Convention on Psychotropic Substances. The implementing Decision implements Decision 2005/387/JHA that confers upon the Council implementing powers with a view to giving a quick and expertise-based response at Union level to the emergence of new psychoactive substances detected and reported by the Member States, by subjecting those substances to control measures across the Union. A risk assessment report on the new psychoactive substance α-PVP was drawn up in accordance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). There is no available information or any published study assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects to those observed in other stimulants. Despite the limited scientific evidence available on α-PVP, the evidence and information on the health risks that the substance poses , as documented in its detection in fatalities and acute intoxications, provides sufficient grounds for subjecting α-PVP to control measures across the Union. By 3 July 2017 , Member States shall take the necessary measures, in accordance with their national law, to subject the new psychoactive substance to control measures and criminal penalties, as provided for under their legislation, complying with their obligations under the 1971 United Nations Convention on Psychotropic Substances. The United Kingdom is not bound by Decision 2005/387/JHA and is therefore not taking part in the adoption of this Decision, which implements Decision 2005/387/JHA, and is not bound by it or subject to its application. ENTRY INTO FORCE: 3.8.2016. docs: title: Decision 2016/1070 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32016D1070 title: OJ L 178 02.07.2016, p. 0018 url: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2016:178:TOC
links
other	body: EC dg: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
procedure/Modified legal basis	Old Rules of Procedure of the European Parliament EP 150 New Rules of Procedure EP 159
procedure/dossier_of_the_committee	Old LIBE/8/05453 New LIBE/8/05453
procedure/final/url	Old http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32016D1070 New https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32016D1070
procedure/subject	Old 4.20.03 Drug addiction, alcoholism, smoking 7.30.30.04 Action to combat drugs and drug-trafficking New 4.20.03 Drug addiction, alcoholism, smoking 7.30.30.04 Action to combat drugs and drug-trafficking
procedure/title	Old Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures. Implementing Decision New Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures

2016-07-06Show (6) Changes | Timetravel

activities/6	date 2016-06-27T00:00:00 body CSL type Council Meeting council Agriculture and Fisheries meeting_id 3479
activities/7	date 2016-06-27T00:00:00 body EP type End of procedure in Parliament
activities/8	date 2016-06-27T00:00:00 body EP/CSL type Act adopted by Council after consultation of Parliament
activities/9	date 2016-07-02T00:00:00 docs url: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32016D1070 title: Decision 2016/1070 url: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2016:178:TOC title: OJ L 178 02.07.2016, p. 0018 type Final act published in Official Journal
procedure/final	url http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32016D1070 title Decision 2016/1070
procedure/stage_reached	Old Awaiting final decision New Procedure completed

2016-07-05Show (1) Changes | Timetravel

procedure/title

Old

New psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, α-PVP): control measures

New

Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures. Implementing Decision

2016-06-17Show (1) Changes | Timetravel

activities/5/docs/0/text

The European Parliament adopted by 646 votes to 7, with 21 abstentions, a legislative resolution on the draft Council decision on subjecting the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures.

In line with the recommendation made by the Committee on Civil Liberties, Justice and Home Affairs, Parliament approved the draft Council decision which aims to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union.

2016-06-10Show (3) Changes | Timetravel

activities/5/docs	url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0258 type: Decision by Parliament, 1st reading/single reading title: T8-0258/2016
activities/5/type	Old Vote in plenary scheduled New Decision by Parliament, 1st reading/single reading
procedure/stage_reached	Old Awaiting Parliament 1st reading / single reading / budget 1st stage New Awaiting final decision

2016-06-05Show (1) Changes | Timetravel

activities/4/docs/0/text

The Committee on Civil Liberties, Justice and Home Affairs adopted, in the framework of a special legislative procedure (Parliament’s consultation), the report by Michał BONI (EPP, PL) on the draft Council decision on subjecting the new psychoactive substance 1phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, αPVP) to control measures.

The committee approved the draft Council decision without amendments.

To recall, the proposed Decision seeks to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union.

2016-05-28Show (2) Changes | Timetravel

activities/5/date	Old 2016-06-07T00:00:00 New 2016-06-08T00:00:00
activities/5/type	Old Indicative plenary sitting date, 1st reading/single reading New Vote in plenary scheduled

2016-05-26Show (1) Changes | Timetravel

activities/4/docs

url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0175&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0175/2016

2016-05-12Show (2) Changes | Timetravel

activities/4

date: 2016-05-10T00:00:00

body: EP

type: Committee report tabled for plenary, 1st reading/single reading

committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP shadows: group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: Verts/ALE name: VALERO Bodil responsible: True committee: LIBE date: 2016-02-29T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał

procedure/stage_reached

Old

Awaiting committee decision

New

Awaiting Parliament 1st reading / single reading / budget 1st stage

2016-05-05Show (2) Changes | Timetravel

activities/3

date: 2016-04-28T00:00:00

body: EP

type: Vote in committee, 1st reading/single reading

committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP shadows: group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: Verts/ALE name: VALERO Bodil responsible: True committee: LIBE date: 2016-02-29T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał

procedure/Modified legal basis

Rules of Procedure of the European Parliament EP 150

2016-04-23Show (2) Changes | Timetravel

activities/2/committees/1/shadows	group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: Verts/ALE name: VALERO Bodil
committees/1/shadows	group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: Verts/ALE name: VALERO Bodil

2016-04-13Show (3) Changes | Timetravel

activities/2	date 2016-04-11T00:00:00 body EP type Committee referral announced in Parliament, 1st reading/single reading committees body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: True committee: LIBE date: 2016-02-29T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał
procedure/dossier_of_the_committee	LIBE/8/05453
procedure/stage_reached	Old Preparatory phase in Parliament New Awaiting committee decision

2016-04-06Show (1) Changes | Timetravel

activities/2

date: 2016-06-07T00:00:00

body: EP

type: Indicative plenary sitting date, 1st reading/single reading

2016-03-30Show (1) Changes | Timetravel

activities/1/docs/0/text

PURPOSE: to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures.

PROPOSED ACT: Council Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: a risk assessment report on the new psychoactive substance α-PVP was drawn up in compliance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction, and was subsequently submitted to the Commission and to the Council on 27 November 2015.

α-PVP is a potent psychostimulant, structurally related to cathinone, pyrovalerone and Methylendioxypyrovaleron (MDPV) which are controlled under the 1971 United Nations Convention on Psychotropic Substances.

There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected.

α-PVP has no established or acknowledged medical use (human or veterinary).

Despite the limited scientific evidence available on α-PVP, the evidence and information on the health risks that the substance poses, as documented in its detection in fatalities and acute intoxications, provides sufficient ground for subjecting α-PVP to control measures across the Union.

CONTENT: the proposed Decision seeks to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures across the Union.

Since sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it, subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.

For further details, please report to the summary of the Commission’s initial legislative proposal of 18.12.2015.

2016-03-17Show (1) Changes | Timetravel

activities/0/docs/0/text

PURPOSE: to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.
PROPOSED ACT: Council Decision.
ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.
BACKGROUND: the risks of α-PVP were assessed by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addition (EMCDDA), acting in compliance with the provisions of Council Decision 2005/387/JHA. In particular, the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substance α-PVP. The Chair of the Scientific Committee submitted the risk assessment report to the Commission and to the Council on 27 November 2015.
α-PVP is a potent psychostimulant. The substance detected in all 28 Member States as well as in Turkey and Norway, is mainly imported into the EU drug market from China and then distributed across Europe.
There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected.
There is no available information or published studies assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects with those observed with other stimulants.
According to the risk assessment report, the acute toxicity of α-PVP is such that it can cause severe harms to the health of individuals. Therefore, the Commission considered that there are grounds for subjecting this substance to control measures across the Union.
CONTENT: the objective of this proposal for a Council Decision is to call upon the Member States to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.
Currently, sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it. Subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.

2016-03-11Show (4) Changes | Timetravel

activities/0/docs/0/text	PURPOSE: to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances. PROPOSED ACT: Council Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: the risks of α-PVP were assessed by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addition (EMCDDA), acting in compliance with the provisions of Council Decision 2005/387/JHA. In particular, the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substance α-PVP. The Chair of the Scientific Committee submitted the risk assessment report to the Commission and to the Council on 27 November 2015. α-PVP is a potent psychostimulant. The substance detected in all 28 Member States as well as in Turkey and Norway, is mainly imported into the EU drug market from China and then distributed across Europe. There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected. There is no available information or published studies assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects with those observed with other stimulants. According to the risk assessment report, the acute toxicity of α-PVP is such that it can cause severe harms to the health of individuals. Therefore, the Commission considered that there are grounds for subjecting this substance to control measures across the Union. CONTENT: the objective of this proposal for a Council Decision is to call upon the Member States to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances. Currently, sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it. Subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.
activities/0/docs/0/type	Old Legislative proposal published New Initial legislative proposal published
activities/0/type	Old Legislative proposal published New Initial legislative proposal published
activities/1	date 2015-12-21T00:00:00 docs url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=15386%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 15386/2015 body EC commission DG: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris type Legislative proposal published

2016-02-27Show (2) Changes | Timetravel

committees/1/date	2016-02-29T00:00:00
committees/1/rapporteur	group: EPP name: BONI Michał

2016-01-21Show (1) Changes | Timetravel

activities/0/docs/0/text

PURPOSE: to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.

PROPOSED ACT: Council Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: the risks of α-PVP were assessed by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addition (EMCDDA), acting in compliance with the provisions of Council Decision 2005/387/JHA. In particular, the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substance α-PVP. The Chair of the Scientific Committee submitted the risk assessment report to the Commission and to the Council on 27 November 2015.

α-PVP is a potent psychostimulant. The substance detected in all 28 Member States as well as in Turkey and Norway, is mainly imported into the EU drug market from China and then distributed across Europe.

There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected.

There is no available information or published studies assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects with those observed with other stimulants.

According to the risk assessment report, the acute toxicity of α-PVP is such that it can cause severe harms to the health of individuals. Therefore, the Commission considered that there are grounds for subjecting this substance to control measures across the Union.

CONTENT: the objective of this proposal for a Council Decision is to call upon the Member States to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.

Currently, sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it. Subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.

2016-01-14Show (5) Changes

activities	date: 2015-12-18T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2015/0674/COM_COM(2015)0674_EN.pdf celexid: CELEX:52015PC0674:EN type: Legislative proposal published title: COM(2015)0674 body: EC type: Legislative proposal published commission: DG: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
committees	body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: True committee_full: Civil Liberties, Justice and Home Affairs committee: LIBE
links
other	body: EC dg: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
procedure	reference 2015/0309(CNS) instrument Decision title New psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, α-PVP): control measures stage_reached Preparatory phase in Parliament subtype Legislation type CNS - Consultation procedure subject 4.20.03 Drug addiction, alcoholism, smoking 7.30.30.04 Action to combat drugs and drug-trafficking

Activites

Documents

History

ParlTrack - 2011-2024